Certainly, given the promising results of this study, our findings justify further exploration of MSI2 signaling mechanism and development of strategies of targeting MSI2 for use in EGFRmut NSCLC, and potentially other tumor types. Here, MSI2 is linked to non-small cell lung carcinoma.